why choose us

First received: July 18, 2023

Clinical Trial: Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in Invasive Lobular Carcinoma

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Carcinoma, Lobular

Study Type: INTERVENTIONAL


Official Title: A Phase 2, Open-label, Non-randomized, Single-center Study to Explore the Diagnostic Performance of [18F]FES PET/CT for the Assessment of Axillary Lymph Node Metastasis in Invasive Lobular Carcin

Brief Summary: This study aims to explore the diagnostic validity of [18F]FES PET/CT for the evaluation of axillary lymph node metastasis in patients with invasive lobular breast cancer having clinically suspected or confirmed axillary lymph node metastasis.

Read more